The Role of miRNAs in Cisplatin-Resistant HeLa Cells

作者: Yubo Yang , Cuihong Dai , Zhipeng Cai , Aiju Hou , Dayou Cheng

DOI: 10.1007/978-3-319-19048-8_30

关键词:

摘要: Chemotherapy is the main strategy in treatment of cancer, however, development drug-resistance obstacle long-term cervical cancer. Cisplatin one most common drugs used cancer therapy. Recently, accumulating evidence suggests that miRNAs are involved various bioactivities oncogenesis. It not unexpected play a key role acquiring progression tumor. In this study, we induced and maintained four levels cisplatin-resistant HeLa cell lines (HeLa/CR1, HeLa/CR2, HeLa/CR3 HeLa/CR4). According to previous studies exiting evidence, selected five (miR-183, miR-182, miR-30a, miR-15b miR-16) their potential target mRNAs as our research targets. The real-time RT-PCR was detect relative expression mRNAs. results show miR-182 were up-regulated resistant while miR-30a significantly down-regulated. At same time, targets they regulated related drug-resistance. alteration compared parent line drug resistance associated with distinct miRNAs, which indicates may be therapy by sensitizing chemotherapy.

参考文章(36)
G Abate, Håkan Miörner, R N Mshana, Evaluation of a colorimetric assay based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis International Journal of Tuberculosis and Lung Disease. ,vol. 2, pp. 1011- 1016 ,(1998)
Zhenyou Zou, Linping Wu, Hanying Ding, Yang Wang, Yaqin Zhang, Xuejiao Chen, Xi Chen, Chen-Yu Zhang, Qipeng Zhang, Ke Zen, MicroRNA-30a Sensitizes Tumor Cells to cis-Platinum via Suppressing Beclin 1-mediated Autophagy Journal of Biological Chemistry. ,vol. 287, pp. 4148- 4156 ,(2012) , 10.1074/JBC.M111.307405
Lin Xia, Dexin Zhang, Rui Du, Yanglin Pan, Lina Zhao, Shiren Sun, Liu Hong, Jie Liu, Daiming Fan, miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. International Journal of Cancer. ,vol. 123, pp. 372- 379 ,(2008) , 10.1002/IJC.23501
Michael Weller, Predicting response to cancer chemotherapy: the role of p53 Cell and Tissue Research. ,vol. 292, pp. 435- 445 ,(1998) , 10.1007/S004410051072
Yu-Quan Wang, Ren-De Guo, Rui-Meng Guo, Wei Sheng, Li-Rong Yin, MicroRNA‐182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas Journal of Cellular Biochemistry. ,vol. 114, pp. 1464- 1473 ,(2013) , 10.1002/JCB.24488
Wei-Qiang Wang, Hao Zhang, Hong-Bin Wang, Yong-Gang Sun, Zhi-Hong Peng, Gang Zhou, Shi-Ming Yang, Rong-Quan Wang, Dian-Chun Fang, Programmed Cell Death 4 (PDCD4) Enhances the Sensitivity of Gastric Cancer Cells to TRAIL-Induced Apoptosis by Inhibiting the PI3K/Akt Signaling Pathway Molecular Diagnosis & Therapy. ,vol. 14, pp. 155- 161 ,(2010) , 10.1007/BF03256368
K Birkenkamp-Demtroder, A Maghnouj, F Mansilla, K Thorsen, C L Andersen, B Øster, S Hahn, T F Ørntoft, Repression of KIAA1199 attenuates Wnt-signalling and decreases the proliferation of colon cancer cells. British Journal of Cancer. ,vol. 105, pp. 552- 561 ,(2011) , 10.1038/BJC.2011.268
R I Aqeilan, G A Calin, C M Croce, miR-15a and miR-16-1 in cancer: discovery, function and future perspectives Cell Death & Differentiation. ,vol. 17, pp. 215- 220 ,(2010) , 10.1038/CDD.2009.69
Fazlul H. Sarkar, Yiwei Li, Zhiwei Wang, Dejuan Kong, Shadan Ali, Implication of microRNAs in drug resistance for designing novel cancer therapy. Drug Resistance Updates. ,vol. 13, pp. 57- 66 ,(2010) , 10.1016/J.DRUP.2010.02.001
Y Yu, L Yang, M Zhao, S Zhu, R Kang, P Vernon, D Tang, L Cao, Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells Leukemia. ,vol. 26, pp. 1752- 1760 ,(2012) , 10.1038/LEU.2012.65